利拉鲁肽
医学
微量白蛋白尿
达帕格列嗪
尿酸
糖尿病
内科学
随机对照试验
2型糖尿病
内分泌学
2型糖尿病
作者
Ting Ou,Wen Wang,Huijuan Yong,Hao Hong,Rongxuan Wang,Xinyu Dai,Dibin Wang,Yuntao Li
出处
期刊:PubMed
日期:2022-09-01
卷期号:28 (6): 14-21
被引量:3
摘要
Liraglutide plus dapagliflozin has highly therapeutic effect for patients with DM complicated with MS and can effectively reduce UA and MAU levels. The current research team will launch a more comprehensive analysis as soon as possible to obtain the most accurate results.
科研通智能强力驱动
Strongly Powered by AbleSci AI